Arthritis Today—June 1, 2016
In the May/June issue of Arthritis Today, Susan M. Goodman, MD, a rheumatologist at Hospital for Special Surgery, comments on a new biologic that is effective for patients with ankylosing spondylitis (AS) or psoriatic arthritis (PsA) called secukinumab (Cosentyx). Dr. Goodman mentions that, "Secukinumab is an important treatment option."
To read more, visit Arthritis.org. (Subscription required)